Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |